Araki, T.; Hamada, K.; Myat, A.B.; Ogino, H.; Hayashi, K.; Maeda, M.; Tong, Y.; Murakami, Y.; Nakao, K.; Masutani, M.
Enhanced Cytotoxicity on Cancer Cells by Combinational Treatment of PARP Inhibitor and 5-Azadeoxycytidine Accompanying Distinct Transcriptional Profiles. Cancers 2022, 14, 4171.
https://doi.org/10.3390/cancers14174171
AMA Style
Araki T, Hamada K, Myat AB, Ogino H, Hayashi K, Maeda M, Tong Y, Murakami Y, Nakao K, Masutani M.
Enhanced Cytotoxicity on Cancer Cells by Combinational Treatment of PARP Inhibitor and 5-Azadeoxycytidine Accompanying Distinct Transcriptional Profiles. Cancers. 2022; 14(17):4171.
https://doi.org/10.3390/cancers14174171
Chicago/Turabian Style
Araki, Tomonori, Kensuke Hamada, Aung Bhone Myat, Hideki Ogino, Kohei Hayashi, Miho Maeda, Ying Tong, Yasufumi Murakami, Kazuhiko Nakao, and Mitsuko Masutani.
2022. "Enhanced Cytotoxicity on Cancer Cells by Combinational Treatment of PARP Inhibitor and 5-Azadeoxycytidine Accompanying Distinct Transcriptional Profiles" Cancers 14, no. 17: 4171.
https://doi.org/10.3390/cancers14174171
APA Style
Araki, T., Hamada, K., Myat, A. B., Ogino, H., Hayashi, K., Maeda, M., Tong, Y., Murakami, Y., Nakao, K., & Masutani, M.
(2022). Enhanced Cytotoxicity on Cancer Cells by Combinational Treatment of PARP Inhibitor and 5-Azadeoxycytidine Accompanying Distinct Transcriptional Profiles. Cancers, 14(17), 4171.
https://doi.org/10.3390/cancers14174171